Luzelena Caro
8PUBLICATIONS
43CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jul 22, 2025
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients With COVID-19 (BIRCH): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.Anca Streinu-Cercel, Antonella Castagna, Shan-Chwen Chang
|Feb 13, 2025
Pharmacokinetics of SARS-CoV-2 RNA Polymerase Inhibitor Remdesivir in Participants With Moderate and Severe Hepatic Impairment.Sean Regan, Rita Humeniuk, Luzelena Caro
|Jan 31, 2025
Clinical Evaluation of Drug-Drug Interactions with Obeldesivir, an Orally Administered Antiviral Agent.Chi-Chi Peng, Rita Humeniuk, Anuja Raut
|Jun 28, 2024
Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants.Olena Anoshchenko, Mazin Abdelghany, Amos Lichtman
|Feb 15, 2023
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study.Regino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires
|Feb 02, 2021
Evaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorvastatin in Healthy Adults.Luzelena Caro, Thomayant Prueksaritanont, Christine M Fandozzi
Pageof 2
Frequent Collaborators
4 joint publications
Rita Humeniuk
3 joint publications
Robert H Hyland
2 joint publications
Deqing Xiao
2 joint publications
Yiannis Koullias
2 joint publications
Helen Winter
2 joint publications
Amos Lichtman
2 joint publications
Mazin Abdelghany
1 joint publications
Stefan Wirth
1 joint publications
Thomas Lang
1 joint publications
Malgorzata Pawlowska
